(a) A licensee shall maintain a record of dosage determinations required by § 35.63 for 3 years.
(b) The record must contain—
(1) The radiopharmaceutical;
(2) The patient's or human research subject's name, or identification number if one has been assigned;
(3) The prescribed dosage, the determined dosage, or a notation that the total activity is less than 1.1 MBq (30 µCi);
(4) The date and time of the dosage determination; and
(5) The name of the individual who determined the dosage.
authority: Atomic Energy Act of 1954, secs. 81, 161, 181, 182, 183, 223, 234, 274 (
42 U.S.C. 2111,
2201,
2231,
2232,
2233,
2273,
2282,
2021; Energy Reorganization Act of 1974, secs. 201, 206 (
42 U.S.C. 5841,
5846;
44 U.S.C. 3504 note
source: 67 FR 20370, Apr. 24, 2002, unless otherwise noted.
cite as: 10 CFR 35.2063